IP Library Granted Patent US 9,238,149
Granted Patent B2
US 9,238,149 · App. 13/230,415 · Granted Jan 19, 2016

Prevention and treatment of alzheimer'S disease through electromagnetic field exposure

Inventors: Gary W. Arendash (Prescott, AZ); Chuanhai Cao (Temple Terrace, FL); Jun Tan (Tampa, FL)
Assignee: UNIVERSITY OF SOUTH FLORIDA
A61N5/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,149
App. No.
13/230,415
Granted
Jan 19, 2016
Kind
B2
Abstract

The invention includes a method of treating and preventing a neurological disorder, such as Alzheimer's Disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period. Preferably, each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule (preferably daily) for a predetermined treatment period. The predetermined frequency, according to a preferred embodiment, is about 918 MHz with a specific absorption rate (SAR) of about 0.25 W/kg+/−2 dB. The predetermined absorption period of this preferred embodiment is about one hour. The treatment period is long-term, being greater than about 6 months and preferably between about 7 and 9 months.

Claims (32)

1. A method of treating and preventing a symptom associated with Alzheimer's Disease in a subject, wherein said symptom is associated with amyloid deposit or cognitive ability, comprising:

positioning an electromagnetic field emitting source proximal to the subject;

exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz;

continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period greater that about three (3) days; and

reversing or reducing cognitive impairment or amyloid aggregation in said subject, decreasing a rate of amyloid deposition, or enhancing cognitive performance in said subject based on said step of continuing exposure for greater than about three (3) days.

2. The method of claim 1 , wherein the predetermined frequency is about 918 MHz.

3. The method of claim 1 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg.

4. The method of claim 1 , wherein the predetermined absorption period is about one hour twice daily.

5. The method of claim 1 , wherein the predetermined treatment period is greater than about 4 months.

6. The method of claim 1 , wherein the predetermined treatment period is between about 7 and 9 months.

7. The method of claim 1 , wherein an enhancement of said cognitive performance in said subject is indicated by an enhancement of working or short-term memory performance of said subject.

8. A method of treating and preventing an amyloid-related neurological disorder in a subject thereof, comprising:

positioning an electromagnetic field emitting source proximal to the subject;

exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz;

continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period greater than about three (3) days; and

reversing or reducing cognitive impairment or amyloid aggregation in said subject, decreasing a rate of amyloid deposition, or enhancing cognitive performance in said subject based on said step of continuing exposure for greater than about three (3) days.

9. The method of claim 8 , wherein the predetermined frequency is about 918 MHz.

10. The method of claim 8 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg.

11. The method of claim 8 , wherein the predetermined absorption period is about one hour twice daily.

12. The method of claim 8 , wherein the predetermined treatment period is greater than about 4 months.

13. The method of claim 8 , wherein the predetermined treatment period is between about 7 and 9 months.

14. The method of claim 8 , wherein an enhancement of said cognitive performance in said subject is indicated by an enhancement of working or short-term memory performance of said subject.

15. A method of enhancing cognitive function in a normal, cognitively unimpaired subject, comprising:

positioning an electromagnetic field emitting source proximal to the subject;

exposing the subject to electromagnetic treatment by an electromagnetic field generated by a digital signal generator, said electromagnetic field having a predetermined frequency for a predetermined absorption period, said predetermined frequency having a range of about 902 MHz to about 928 MHz;

continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period; and

enhancing cognitive performance of said subject based on said step of continuing exposure for said predetermined treatment period, wherein said enhancing cognitive performance of said subject includes enhancing working memory performance of said subject.

16. The method of claim 15 , wherein the predetermined frequency is about 918 MHz.

17. The method of claim 15 , wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg to about 1.6 W/kg.

18. The method of claim 15 , wherein the predetermined absorption period is about one hour twice daily.

19. The method of claim 15 , wherein the predetermined treatment period is greater than about three (3) days.

20. The method of claim 15 , wherein the predetermined treatment period is greater than about four (4) months.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2018
From: UNIVERSITY OF SOUTH FLORIDA
To: UNIVERSITY OF SOUTH FLORIDA; UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 047458/0386 →
CONFIRMATORY LICENSE Recorded Jun 30, 2016
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039217/0785 →
CONFIRMATORY LICENSE Recorded Dec 13, 2011
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027372/0623 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2011
From: ARENDASH, GARY W.; CAO, CHUANHAI; TAN, JUN
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 027343/0990 →
Continuity (3)
Continuation PCTUS2010026952 · Mar 11, 2010
Provisional Application 61159251 · Mar 11, 2009
Related Publication 20120065456A1 · Mar 15, 2012